Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hereditary hemochromatosis (HH) is a disorder of iron metabolism caused by common mutations in the gene HFE. The HFE protein binds to transferrin receptor-1 (TfR1) in competition with transferrin, and in vitro, reduces cellular iron by reducing iron uptake. However, in vivo, HFE is strongly expressed by liver macrophages and intestinal crypt cells, which behave as though they are relatively iron-deficient in HH. These latter observations suggest, paradoxically, that expression of wild-type HFE may lead to iron accumulation in these specialized cell types. Here we show that wild-type HFE protein raises cellular iron by inhibiting iron efflux from the monocytemacrophage cell line THP-1, and extend these results to macrophages derived from healthy individuals and HH patients. In addition, we find that the HH-associated mutant H41D has lost the ability to inhibit iron release despite binding to TfR1 as well as wild-type HFE. Finally, we show that the ability of HFE to block iron release is not competitively inhibited by transferrin. We conclude that HFE has two mutually exclusive functions, binding to TfR1 in competition with Tf, or inhibition of iron release.

Original publication

DOI

10.1073/pnas.242614699

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

26/11/2002

Volume

99

Pages

15602 - 15607

Keywords

Amino Acid Substitution, Binding, Competitive, Biological Transport, Ferritins, HeLa Cells, Hemochromatosis, Hemochromatosis Protein, Histocompatibility Antigens Class I, Humans, Iron, Macrophages, Membrane Proteins, Models, Molecular, Monocytes, Mutation, Protein Conformation, Recombinant Fusion Proteins, Transferrin, Tumor Cells, Cultured, U937 Cells